
Academic Journal
Q1Annals of Neurology
About Annals of Neurology
Annals of Neurology is a scholarly journal published by John Wiley & Sons Inc.. SCImago 2025 places it in Q1 with an SJR of 3.247 and an H-index of 350.
Its listed coverage is 1977-2026 and its research categories include Neurology (Q1); Neurology (clinical) (Q1). The 2025 dataset reports 289 documents and 4864 citations across the latest three-year reporting window.
The Annals of Neurology is a leading peer-reviewed scientific journal dedicated to the field of neurology. Established in 1977, this prestigious publication has been at the forefront of advancing the understanding of neurological disorders and diseases. With a focus on the latest research, breakthroughs, and treatments, it plays a pivotal role in shaping the future of neurology worldwide.
A Comprehensive Journal for Neurological Research
Annals of Neurology covers a wide range of topics within the field of neurology, including but not limited to, neurodegenerative diseases, brain injuries, stroke, epilepsy, multiple sclerosis, and neurogenetics. The journal publishes original research articles, reviews, case reports, and clinical studies, ensuring that it serves as a reliable source of information for both researchers and clinicians.
One of the primary goals of Annals of Neurology is to provide a platform for groundbreaking research that improves the understanding and treatment of neurological disorders. By publishing high-quality studies, the journal helps in the development of new therapeutic strategies and enhances the overall care of patients with neurological conditions.
Impact Factor and Recognition in the Medical Community
The Annals of Neurology is highly regarded within the scientific and medical communities. It has maintained an impressive impact factor, reflecting its significant contribution to the advancement of neurology. The journal's editorial board consists of some of the most respected neurologists and researchers from around the world, ensuring that only the highest standard of research is published.
The journal’s impact factor, a metric that indicates the frequency with which its articles are cited, serves as a testament to its importance in the field. Researchers and medical professionals turn to Annals of Neurology for the latest studies, evidence-based findings, and innovative treatments that are shaping the future of neurology.
Advancements in Neurology Through Annals of Neurology
The Annals of Neurology has been instrumental in publishing research that has led to significant advancements in the treatment of neurological diseases. From pioneering studies on Alzheimer’s disease to cutting-edge research in gene therapy for neurological conditions, the journal continues to push the boundaries of knowledge.
Notable breakthroughs published in Annals of Neurology include the discovery of novel biomarkers for early detection of Parkinson’s disease and advancements in neuroimmunology, which have transformed the understanding of autoimmune neurological disorders. These contributions have a direct impact on clinical practices and help improve the quality of life for individuals living with neurological diseases.
The Role of Annals of Neurology in Education and Training
In addition to its role in publishing new research, Annals of Neurology plays a vital role in educating and training the next generation of neurologists. The journal serves as an essential resource for medical students, residents, and fellows, providing them with access to the latest developments in the field.
By featuring articles that highlight both basic science and clinical applications, the journal ensures that its readers remain informed about the most current advances in neurological practice. The accessibility of Annals of Neurology to medical professionals around the globe ensures that it is a key resource for those committed to furthering their knowledge of neurology.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
Annals of Neurology is a highly respected and peer-reviewed scientific journal dedicated to advancing the field of neurology. Established in 1977, it has long been a significant platform for publishing groundbreaking research in various subfields of neurology. The journal focuses on a wide range of topics, from fundamental neurological disorders to emerging therapeutic strategies and cutting-edge research in neuroscience. By maintaining high standards of quality and rigor, Annals of Neurology has become a key source of information for clinicians, researchers, and healthcare professionals worldwide.
Focus Areas of Annals of Neurology
Annals of Neurology covers an extensive array of neurological conditions, including but not limited to:
-
Neurodegenerative Diseases: The journal features critical studies on Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and other neurodegenerative conditions. These articles help deepen understanding of disease mechanisms, diagnostics, and potential therapies, providing valuable insights for improving patient care and management.
-
Stroke and Cerebrovascular Disorders: Research on stroke pathophysiology, early intervention, recovery, and rehabilitation is an integral part of the journal. Annals of Neurology publishes studies that inform clinical practice regarding stroke prevention, acute treatment, and long-term care for survivors.
-
Multiple Sclerosis (MS) and Other Autoimmune Neurological Disorders: The journal highlights studies focused on multiple sclerosis, autoimmune encephalitis, and other immune-mediated neurological conditions. Research on biomarkers, immune modulation, and emerging treatment options is of significant interest to both clinicians and researchers.
-
Epilepsy: Epilepsy research, including seizure mechanisms, diagnosis, treatment approaches, and innovative therapies such as neuromodulation, is thoroughly explored in Annals of Neurology. This helps provide insights into improving the quality of life for patients living with epilepsy.
-
Neurogenetics and Genetic Disorders: The journal covers the rapidly evolving field of neurogenetics, emphasizing genetic mutations, inheritance patterns, and the impact of genetic research on diagnosing and treating neurological disorders. It features studies on genetic testing, gene therapy, and personalized medicine.
-
Neuroimmunology: Research on the intersection of the immune system and the nervous system is another key area covered. Studies on neuroinflammation, immune responses in neurological diseases, and the development of immunotherapies are regularly featured in the journal.
Clinical Neurology and Translational Research
Annals of Neurology stands out by not only publishing basic science research but also by placing a strong emphasis on clinical applications and translational research. The journal bridges the gap between laboratory discoveries and real-world clinical practices, offering valuable insights into patient treatment protocols, diagnostic advancements, and future therapeutic interventions. Articles on clinical trials, pharmacological interventions, and personalized approaches to treatment are regularly featured.
Impact Factor and Global Influence
With a consistently high impact factor, Annals of Neurology has established itself as a leader in the field of neurology. The journal attracts contributions from some of the most prominent researchers, clinicians, and institutions worldwide. Its global influence extends beyond academia to influence policy-making, clinical guidelines, and public health initiatives in the field of neurology.
Recent Research Articles
Latest publications matched automatically by ISSN.
Non‐contrast CT Markers of Hematoma Expansion and Andexanet Response in Factor Xa Inhibitor‐Associated Intracerebral Hemorrhage: An Analysis from ANNEXa ‐I Trial
Koji Tanaka, Umberto Pensato, Mohamed Alshamrani, Aristeidis H. Katsanos et al.
2026-09-08 · DOI: 10.1002/ana.78347Coiled and Intertwined Middle Cerebral Artery
Mingyao Li, Zhen Liu, Yongnan Hao, Shuhu Zhou et al.
2026-09-07 · DOI: 10.1002/ana.78359Tracking Socio‐emotional Brain Changes in Premanifest C9orf72 Repeat Expansion Carriers: A Structural and Functional 2‐Year Longitudinal Magnetic Resonance Imaging Study
Jiaze Sun, Joke De Vocht, Maarten Laroy, Daphne Stam et al.
2026-09-07 · DOI: 10.1002/ana.78355Hippocampal Seizure‐Related Burden is Associated with Accelerated Long‐Term Forgetting in Focal Epilepsy
Ionuț‐Flavius Bratu, Isabelle Lambert, Olivier Felician, Samuel Medina Villalon et al.
2026-09-03 · DOI: 10.1002/ana.78354Aspergillus Ventriculitis
Yu‐Wei Hsu, Hao‐Hsiang Hsu, Pang‐Shuo Perng
2026-09-02 · DOI: 10.1002/ana.78360T Cell‐Mediated Targeting of Interneurons in Mice Shapes Hippocampal Remodeling and Epilepsy
Daniel S. Galvis‐Montes, Lukas Henning, Karen M. J. van Loo, Rainer Surges et al.
2026-09-02 · DOI: 10.1002/ana.78349Cofilin 1 Is an Extracellular Vesicle‐Associated Plasma Biomarker of Parkinson's Disease in Humans
Deepthy Chandran, Unnati Agrawal, Deepa Damayanthi, Divya T. Nair et al.
2026-09-01 · DOI: 10.1002/ana.78348Multimodal Characterization of Glymphatic‐Related Magnetic Resonance Imaging Markers in Huntington's Disease: A Multi‐Cohort Retrospective Study
Alexia Solomon, Zexi Wang, Francesco Sanvito, Zheng Zhou et al.
2026-08-31 · DOI: 10.1002/ana.78344Effects of an Inpatient Program on Medication Errors in Hospitalized People with Parkinson's Disease
Camila C. Piccinin, Jeryl Ritzi T. Yu, Victoria Stepanyants, Olivia Hogue et al.
2026-08-31 · DOI: 10.1002/ana.78345Therapeutic Prospects of Ketamine for Cataplexy in Narcolepsy Type 1: Evidence from a Human Case and a Murine Model
Francois Ricordeau, Sebastien Arthaud, Leila Langbour, Silvia Melzi et al.
2026-08-28 · DOI: 10.1002/ana.78343Degos Disease Presenting as a Hemorrhagic Brain Mass
Junjiang Wu, Fan Lin
2026-08-28 · DOI: 10.1002/ana.78338Cerebrospinal Fluid Amyloid‐β Risk Stratification in Cerebral Amyloid Angiopathy: A Missing Link for Anti‐Amyloid Therapy Safety
Hajime Takase
2026-08-26 · DOI: 10.1002/ana.78337Reply to “ CSF Amyloid‐β Risk Stratification in CAA : A Missing Link for Anti‐Amyloid Therapy Safety”
Philipp Arndt, Stefanie Schreiber
2026-08-26 · DOI: 10.1002/ana.78339Cortical Thickness and White Matter Surface Morphology in Tourette Syndrome: A Cohort Study
Sahar Delavari, Adam C. Frank, Ravi Bansal, Flora M. Vaccarino et al.
2026-08-25 · DOI: 10.1002/ana.78340Accelerated Brain Atrophy in Epilepsy: A Prospective Population‐Based Study
Marian Galovic, Rebecca S. N. Liu, Alex D. Everitt, Robert Terziev et al.
2026-08-24 · DOI: 10.1002/ana.78319Pancake‐Like Enhancement in Spondylotic Compressive Myelopathy
Wei Z. Yeh, Shisheng Lu
2026-08-21 · DOI: 10.1002/ana.78341Annals of Neurology: Volume 100, Number 3, September 2026
2026-09 · DOI: 10.1002/ana.78330Issue Information
2026-09 · DOI: 10.1002/ana.78329Challenges in Studying Synapses in Alzheimer's Disease
Thomas C. Südhof
2026-08-20 · DOI: 10.1002/ana.78331Reviews
Community Reviews
Version History
April 21, 2025 at 10:38 am
April 21, 2025